Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Pharmaceutics|August 10, 2021
Rapid and Sensitive Quantification of Intracellular Glycyl-Sarcosine for Semi-High-Throughput Screening for Inhibitors of PEPT-1Teresa von Linde, Gzona Bajraktari-Sylejmani, Walter E Haefeli, et al.
British Journal of Clinical Pharmacology|April 4, 2017
Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokineticsNicolas Hohmann, Rebecca Kreuter, Antje Blank, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 26, 2019
A follow-up report on potential drug interactions with clementines: Two single case experiments show no effect on CYP3A-dependent midazolam clearanceNicolas Hohmann, Gerd Mikus, Walter Emil Haefeli, et al.
Pharmaceutics|January 25, 2025
Effect of Staggered vs. Simultaneous Co-Administration of Bempedoic Acid on Pharmacokinetics of Pravastatin: Randomized, Cross-Over Clinical Trial in Healthy VolunteersFelicitas Stoll, Salvatore Amato, Max Sauter, et al.
Clinical Pharmacokinetics|May 30, 2016
Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of VoriconazoleNicolas Hohmann, Franziska Kocheise, Alexandra Carls, et al.
Chemico-Biological Interactions|February 11, 2010
Factors determining sensitivity or resistance of tumor cell lines towards artesunateSerkan Sertel, Tolga Eichhorn, Sebastian Sieber, et al.
Pharmacology|September 25, 2009
Interaction of thiazolidinediones (glitazones) with the ATP-binding cassette transporters P-glycoprotein and breast cancer resistance proteinJohanna Weiss, Alexandra Sauer, Melanie Herzog, et al.
Journal of Clinical Pharmacology|August 14, 2013
Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activityFelicitas Stoll, Jürgen Burhenne, Berthold Lausecker, et al.
Clinical Pharmacology and Therapeutics|July 2, 2004
Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteersReinhard Ding, Yorki Tayrouz, Klaus-Dieter Riedel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal FailureMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Pageof 19